PCDH19 and epilepsy: Higurashi et al. also found high levels of N-methyl-D-aspartate (NMDA)-type glutamate receptor (abs-NR) in the serum or cerebrospinal fluid (CSF); Abs-NR could pass the BBB because it is susceptible in patients with PCDH19-related epilepsy.